Preterm Birth and Multiple Gestation
Transcription
Preterm Birth and Multiple Gestation
Is Planned Cesarean Birth for Twin Pregnancy Justified? Jon FR Barrett MBBCh, MD, FRCOG FRCSC Sunnybrook Health Science Centre University of Toronto Objectives • To review current practice guidelines for delivery of term twins • To discuss the influence of mode of delivery on perinatal outcome in the second twin • To evaluate available evidence for planned cesarean birth for twins ≥ 32 weeks • To present the current status of the Twin Birth Study (TBS) Delivery of Twin A Breech – Cesarean section – Vaginal delivery Cephalic – Spontaneous vaginal delivery – Vacuum or forceps – Cesarean section Delivery of Twin B Cephalic – Await descent, amniotomy, deliver – Vacuum or forceps – Internal podalic version, breech extraction – Cesarean section Delivery of Twin B Breech – Await descent (amniotomy) deliver – Breech extraction – Cesarean section Transverse – Breech extraction – Cesarean section Clinical Practice Guidelines SOGC (No. 91, 2000) • Indications for elective Cesarean section • Monoamniotic twins • Conjoined twins • Vaginal delivery of Twin B if 1500-4000g ACOG (No. 56, 2004) • Twin A vertex, B vertex … Vaginal delivery • Twin A nonvertex … Cesarean section • Twin A vertex, B nonvertex … Controversial Clinical Practice Guidelines French College (CNGOF 2011) • Optimal MOD unclear • Active delivery of second twin • Breech extraction for breech, transverse or high cephalic presentation RCOG (2006) • Optimal MOD>32 weeks unclear NICE (2011) • CS when first twin non-cephalic What are we doing? Delivery of Twins < 32 Weeks Delivery of Twins 32-38 Weeks 500 500 450 450 400 400 350 350 300 300 250 250 200 200 150 150 100 100 50 50 0 0 Vtx /Vtx Vtx /Breech Breech/Vtx Planned vaginal delivery Vtx /Vtx Vtx /Breech Breech/Vtx Planned Cesarean section Hutton et al. (2002) JOGC Cesarean Rates for Twins in USA The Second Twin Determinants of Perinatal Mortality and Serious Neonatal Morbidity in the Second Twin B. Anthony Armson Vidia Persad KS Joseph Colleen O’Connell David Young Thomas Baskett Obstet Gynecol 2006; 108:556-64 Methods • Retrospective cohort study of twins 500 gm • NS Atlee Perinatal Database 1988-1992. • Exclusions: Birthweight < 500 gm Monoamniotic/conjoined twins Major congenital anomalies Prelabor fetal death of either twin • Matched pair analysis Obstet Gynecol 2006; 108:556-64 Primary Outcome • • • • • Perinatal Death Birth Asphyxia Respiratory Distress Syndrome Neonatal Infection Birth Trauma Obstet Gynecol 2006; 108:556-64 Composite Perinatal Morbidity by Gestational Age Gestational Age (N) All (1542) Twin 1 n (rate/1000) Twin 2 n (rate/1000) RR (95% CI) p 108 (70.0) 175 (113.5) 1.6(1.38-1.90) <0.001 37 weeks (876) 11 (12.6) 29 (33.1) 2.6(1.36-5.09) 0.003 34-36 weeks (478) 20 (41.8) 48 (100.4) 2.4(1.56-3.69) <0.001 <34 weeks (188) 77(409.6) 98 (521.3) 1.3(1.10-1.48) <0.001 Obstet Gynecol 2006; 108:556-64 Perinatal Mortality and Serious Neonatal Morbidity (n = 1542) Morbidity Twin 1 n (rate/1000) Twin 2 n (rate/1000) RR (95% CI) p Birth Asphyxia 28 (18.2) 48 (31.1) 1.74(1.14-2.58) 0.009 Respiratory Distress 75 (48.6) 131(84.9) 1.75(1.44-2.11) <0.001 Neonatal Infection 31 (20.1) 28 (18.2) 0.84(0.56-1.25) 0.38 3 (1.9) 7 (4.5) 2.33(0.69-7.82) 0.16 10 (6.5) 13 (8.4) 1.3 (0.82-2.05) 0.26 Birth Trauma Perinatal Death Composite Morbidity 108 (70.0) 175 (113.5) 1.62(1.38-1.90) <0.001 Obstet Gynecol 2006; 108:556-64 Determinants of Morbidity in the Second Twin YES NO • Planned VD • Birthweight discordance T1 < T2 by > 20% • Prolonged interdelivery interval • Combined VD/CS • Presentation • Chorionicity • Infant Sex Obstet Gynecol 2006; 108:556-64 Mode of Delivery Gestational Age (N) 37 weeks (876) Mode of Delivery (N) Twin 1 n (rate/1000) Twin 2 n (rate/1000) RR (95% CI) p Planned CS (183) Planned VD (693) 2 (10.9) 9 (13.0) 2 (10.9) 27 (39.0) 1.0 (0.14-7.10) 3.0 (1.47-6.11) 1 <0.001 34-36 weeks (478) Planned CS (83) Planned VD (395) 4 (48.2) 16 (40.5) 14 (168.7) 34 (86.8) 3.5 (1.31-9.32) 2.1 (1.32-3.42) 0.006 <0.001 < 34 weeks (188) Planned CS (28) Planned VD(160) 15 (535.7) 62 (387.5) 15 (535.7) 83 (518.8) 1.0 (0.73-1.38) 1.3 (1.13-1.58) 1 <0.001 All (1542) Planned CS (294) Planned Vag(1248) 21 (71.4) 87 (69.7) 31 (105.4) 144 (115.4) 1.5 (1.01-2.15) 1.7 (1.39-1.97) 0.04 <0.001 Obstet Gynecol 2006; 108:556-64 Delivery-related Perinatal Death among Term Twins • • • • Retrospective cohort study Scotland (1985-2001, n=8073) Perinatal Deaths: T1 – 6; T2 – 30 (OR 5 for T2) Risk of death due to intrapartum anoxia - OR 21 for 2nd twin • PMR with planned CS = 0.14% • PMR with planned VB = 0. 52% (p=0.05) • Planned CS may reduce perinatal death in twins by 75% by reducing risk of intrapartum anoxia in the 2nd twin Smith GS, BJOG 2005 RCT of Vaginal vs Cesarean Birth for Nonvertex Second Twin Rabinovici: • 60 Vtx/Nvtx twins > 33 weeks • Planned vaginal (33); planned cesarean (27) • No difference in Apgar scores or neonatal morbidity between groups • For nonvertex second twin, outcome not influenced by mode of delivery Am J Obstet Gynecol 1987;156:52-6 Systematic Reviews • • • • Planned cesarean vs planned vaginal birth ≥ 32weeks gestation 13 cohort studies; 7396 newborns Neonatal mortality and morbidity measures Armson, Barrett – unpublished data Systematic Reviews Hogle K: • 4 studies (1932 infants) • Low 5-minute Apgar score less likely with cesarean • Longer LOS for twins delivered by cesarean Conclusions: • Planned cesarean birth may reduce risk of low 5-minute Apgar, especially if Twin A is breech • No evidence to support planned cesarean birth for twins Am J Obstet Gynecol 2003;188:220-7 Vaginal vs Cesarean Birth? • Conflicting evidence from observational trials • Planned CS may reduce risk of adverse perinatal outcome (Smith 2002, 2007; Armson 2006; Yang 2005) • No evidence of benefit (Zhang 1996; Usta 2002; Sibony 2003) • Vaginal/cesarean birth associated with increased risk of perinatal death (Persad 2001, Wen 2004) Systematic Reviews Steins CN: • 1 RCT (60); 16 cohort studies (3,167) • No difference neonatal outcome between VD and CS in T1 or T2 • T1 in cephalic or non-cephalic presentation – No difference • T2 in non-cephalic presentation: – No difference in neonatal outcome – VD associated with ↑incidence of 5-minute Apgar < 5 in one study Arch Gynecol Obstet 2012;286:237-47 Systematic Reviews Rossi AC: • 18 studies (39,571 twin pregnancies) • Neonatal mortality/morbidity less for T1 than T2 • T1 - ↓ morbidity with VD vs CS (OR=2) – Planned VD vs planned CS → No difference • T2 - ↑ morbidity with combined VD/CS – Planned VD vs planned CS → No difference BJOG 2011;118:523-532 Systematic Reviews Steins CN: • 1 RCT (60); 16 cohort studies (3,167) • No difference neonatal outcome between VD and CS in T1 or T2 • T1 in cephalic or non-cephalic presentation – No difference • T2 in non-cephalic presentation: – No difference in neonatal outcome – VD associated with ↑incidence of 5-minute Apgar < 5 in one study Arch Gynecol Obstet 2012;286:237-47 Systematic Reviews Hofmeyr, Barrett, Crowther 2011: • • • • • One study – Rabinovici 60 Vtx/Nvtx twins No difference in neonatal outcome Sample size too small to inform practice Large RCT required Cochran Review, Dec, 2011 Neonatal Death Armson, Barrett – unpublished data Neonatal Morbidity Armson, Barrett – unpublished data 5 Minute Apgar < 4 Armson, Barrett – unpublished data Umbilical Cord pH < 7.0 Armson, Barrett – unpublished data Severe Respiratory Distress Armson, Barrett – unpublished data Birth Trauma NICU Admission Armson, Barrett – unpublished data Fetal perspective Cohort Meta-analysis Equipoise The Twin Birth Study RCT of planned cesarean (CS) vs planned vaginal birth (VB) for twins 32-38 weeks gestation Research Questions For twin pregnancies of 32-38 weeks gestation, where twin A is presenting vertex, does a policy of planned CS compared to a policy of planned VB: • Primary: decrease the likelihood of stillbirth or neonatal mortality or serious morbidity, during the first 28 days after birth? • Secondary: decrease the risk of death or poor neurodevelopmental outcome of the children at 2 years corrected age? decrease the risk of problematic urinary or faecal/flatal incontinence for the mother at 2 years postpartum? Inclusion Criteria • Gestational age 32 - 38 weeks Estimated weight of each fetus is 1,500g – 4,000g by ultrasound within 7 days of randomization Twin A vertex Twin B any presentation • 20% change • clinical impression Both twins alive Exclusion Criteria Mono-amniotic twins Lethal fetal anomaly of either fetus Contraindication to labour or vaginal delivery of either twin − IUGR − twin B substantially larger than twin A Previous participation in TBS Perinatal/neonatal mortality or serious neonatal morbidity • Death before 28 days of life • Birth trauma: subdural or intracerebral haemorrhage, spinal cord injury, basal or depressed skull fracture, or long bone fracture, peripheral nerve injury present at discharge from hospital • • • • • • • • Apgar < 4 at 5 minutes Coma, stupor or decreased response to pain Neonatal seizures within 72 hours of birth Assisted ventilation via ET-tube for 24 hours within 72 hours after birth Septicemia or meningitis within 72 hrs of birth Necrotising enterocolitis BPD IVH (grade 3 or 4) or cystic PVL Sample Size Total sample = 2800 (1400/group) 80% power 2 - sided error = 0.05 Reduction in risk of perinatal/neonatal mortality or serious neonatal morbidity from 4% (0.04) with planned VB to 2% (0.02) with planned CS Statistical Analysis Interim analyses • after first 1000 and 1800 women recruited • p < 0.002 (2 sided) to stop trial early Final analysis • Intention-to-treat • methods of Donner and Klar (a baby will be the unit of analysis; pregnancy will be treated as a cluster) • p < 0.05 for primary and secondary outcomes • p < 0.01 for other outcomes First twin pair recruited, December 2003 RECRUITMENT GRAPH Twin Birth Study Recruitment Graph 2800 2600 2400 2200 2000 1800 1600 1400 1200 1000 800 600 400 200 0 RECRUITMENT TABLE (projected sample size of 2800) April 30, 2011 COUNTRY ARGENTINA BRAZIL CANADA ISRAEL POLAND UK CHILE SPAIN EGYPT AUSTRALIA THE NETHERLANDS SERBIA USA JORDAN JAMAICA ESTONIA QATAR HUNGARY OMAN ROMANIA GERMANY BELGIUM URUGUAY CROATIA GREECE Total Jan Annual Dec Dec Goal 2003 2004 67 73 84 46 15 68 16 32 20 32 10 11 31 9 4 3 22 4 7 3 9 0 13 0 0 579 3 60 2 25 21 4 2 8 2 19 2 7 65 44 53 27 28 2 11 6 14 15 9 96 71 46 16 18 15 13 10 15 12 17 107 54 41 14 44 18 8 9 6 17 6 4 5 13 5 10 8 5 12 5 11 2 5 3 Jan - Jan - Jan - Jan - Jan - Jan Dec Dec Dec Dec Dec Jun 2005 2006 2007 2008 2009 2010 5 3 7 4 3 182 333 8 8 9 23 7 122 63 29 32 35 16 16 8 12 14 6 27 5 8 14 7 125 97 40 42 25 31 25 7 20 8 5 24 11 6 7 7 6 3 5 5 2 4 3 2 1 373 4 4 3 385 3 3 425 63 43 7 20 10 19 13 10 3 8 4 4 3 7 5 5 10 2 9 1 1 487 245 Jul Dec Jan Feb Mar Apr Grand 2010 2011 2011 2011 2011 Total 60 26 9 19 9 7 1 1 11 7 39 4 4 8 2 9 2 3 7 3 2 25 1 8 1 13 3 3 5 1 4 3 5 9 4 3 4 2 4 6 3 3 1 1 1 1 2 3 2 2 4 3 3 238 43 43 2 1 1 1 42 5 732 414 260 201 167 126 114 108 89 79 63 58 57 56 54 53 42 39 21 18 15 15 10 9 4 2804 2804 Women Randomized 1406 women allocated to planned VB (2812 fetuses) 1398 women allocated to planned CS (2795 fetuses) 6 women (12 fetuses) lost to follow-up 1392 women (2783 fetuses) 13 women (26 fetuses) lost to follow-up 643 had labour (140 delivered vaginally) 2 infants/fetuses lost to follow-up 1393 women (2786 fetuses) 4 infants/fetuses lost to follow-up 1 woman lost to follow-up 2782 infants/fetuses contributed to primary outcome 2781 infant/fetuses contributed to primary outcome 21 neonatal deaths/stillbirths 2760 infants/fetuses contributed to neonatal morbidity 1195 had labour (842 delivered vaginally) 17 neonatal deaths/stillbirths 2765 infants/fetuses contributed to neonatal morbidity 1392 women contributed to maternal outcome Mode of delivery Planned Caesarean Section Planned Vaginal Birth N=1392 N=1393 n (%) n (%) Caesarean section for both 1250 (89.93%) 551 (39.55%) Vaginal delivery for both 129 (9.28%) 783 (56.21%) Vaginal/Caesarean (all Cephalic Twin A) 11 (0.79%) 59 (4.24%) Thank you
Documents pareils
Is planned vaginal delivery for breech presentation at term still an
of Diseases.13 All deaths before dischargedfetal, neonatal, and postneonatal deathsdwere reviewed by an independent expert committee (members listed in Appendix)
to determine the cause of each deat...